Nociceptive Pain
66
8
9
36
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.5%
3 terminated out of 66 trials
92.3%
+5.8% vs benchmark
6%
4 trials in Phase 3/4
6%
2 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 36 completed trials
Clinical Trials (66)
Central Sensitisation in Nociceptive and Neuropathic Pain
Pain Phenotypes in Patients With Fibromyalgia Syndrome
Intraoperative Electroencephalographic Biomarkers of Postoperative Pain
Automatic Remifentanil Administration Guided by ANI During Propofol Anesthesia
Comparison of the Skin Conductance Algesimeter and the Nociception Level Index in the Paediatric Population. An Observational Study.
Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury
Radicle Relief 2: A Study of Health and Wellness Products on Pain and Health Outcomes
FDG PET/MR Imaging of Peripheral Pain Generators
NOL Index in Response to Pacemaker Stimulation
Comparison of the Surgical Pleth Index and the Nociception Level Index in the Pediatric Population
Guiding Opioid Administration by Nociception Level Index (NOL) in Patients With Regional Anesthesia
PET/MRI in the Diagnosis of Pediatric Chronic Pain
Comparison of Different Objective Nociceptive Measurement Methods During Surgery
PET/CT Guided Robotic Arm-assisted Pain Palliation in Chronic Nociceptive Low Backache
Clinical Trial of the invisaRED® IR REHAB Device When Used as an Adjunctive Therapy for Nociceptive Musculoskeletal Pain
Ultra Low Frequency Neuromodulation for Nociceptive Chronic Low Back Pain
Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool
PETMRI for Chronic Pain from Spinal or Peripheral Nerve Origin
Correlation Between NOL Index After Stimulus and Post-operative Opioid, Pain, Pre-operative Phenotype
Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.